Clinical trial
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's…
NCT00278421 · German High-Grade Non-Hodgkin's Lymphoma Study Group, Other · Completed
Key facts
| NCT number | NCT00278421 |
|---|---|
| Title | Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma |
| Official title | Randomized Study Comparing 4 and 6 Cycles of Chemotherapy With CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 21-day Intervals, Both With 6 Cycles of Immunotherapy With the Monoclonal Anti-CD20-Positive B-Cell Lymphoma Aged 18-60 Years Having no Risk Factor (Age-Adjusted IPI=0)… |
| Lead sponsor | German High-Grade Non-Hodgkin's Lymphoma Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | rituximab, cyclophosphamide, doxorubicin hydrochloride, prednisone, vincristine sulfate |
| Enrollment | 592 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2018 |
| Completion | Aug 1, 2018 |
| First posted | Jan 18, 2006 |
| Last update posted | Mar 11, 2021 |
| Countries | Germany, Israel, Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: